Morgan Stanley estimates that 12.4 GW of planned U.S. data-center capacity could be affected by 2030, representing 8% of its forecast cumulative operating capacity by then; the bank believes policy is more likely to delay projects than reduce their ultimate scale.
Adjusted pretax profit from investment and savings products exceeded market consensus, and net inflows were also well above expectations; term life profit and agent productivity were below expectations.
Excluding gains from assumption changes, Aflac’s third-quarter earnings per share fell short of expectations; a cybersecurity incident weighed on expenses and sales in Japan, while the U.S. business exceeded Morgan Stanley’s forecast.
The six preclinical assets were licensed in a deal with a total value of $7 billion, including $358 million in upfront payments. The company remains responsible for development until completion of global Phase I trials, with the first program expected to complete Phase I by the end of 2028.
Morgan Stanley maintains its base case of the S&P 500 Index reaching 8000 points at year-end, but wants further confirmation from sentiment indicators; earnings growth breadth, liquidity and valuation will jointly shape the market’s subsequent trajectory.
Third-quarter net profit came in below Morgan Stanley’s prior expectations, prompting it to lower its earnings forecast for 2026; the bank also cut its valuation multiple, while maintaining its earnings forecasts for 2027–2028 and its Overweight rating.
The company reaffirmed its full-year 2027 profitability target and plans to significantly reduce R&D expenses; however, Crysvita sales in the third quarter were below market expectations, and the rollout of two gene therapies will affect future growth.
The U.S. retirement and individual life businesses lifted core earnings per share above market consensus, but earnings in Japan declined year over year, and Morgan Stanley maintained its Underweight rating.
The US all-electric vehicle market returned to year-over-year growth in October, but sales of Ultium-platform models were still down 18% year over year. Morgan Stanley believes LG Energy Solution’s EV business may be bottoming, while margin recovery is likely to be more gradual.
Morgan Stanley raised its Brent price assumptions and Harbour Energy earnings forecasts, but believes BASF’s planned exit from its stake could mean that a greater share of the incremental cash-flow benefits from buybacks goes to the seller.
Morgan Stanley raised its EPS forecasts for Eaton for 2026–2028, expecting the two Electrical businesses to sustain faster organic growth, while price and cost pressures will limit margin improvement in the Americas business.
AVLAYAH’s third-quarter sales reached 17.8 million dollars, and fourth-quarter guidance also exceeded expectations. Expanded insurance coverage and clinical-trial patients switching to commercial drug use drove growth, but management expects the growth rate to stabilize thereafter.
Market-stabilization funds have driven a rebound in A-share sentiment, but earnings expectations and domestic demand remain weak. Morgan Stanley says the October correction improved the risk-reward profile of some high-quality, oversold stocks, and it continues to favor selective stock picking.
Morgan Stanley expects Asia’s electricity demand to grow at an average annual rate of about 5% by 2030. Constraints on U.S. power supply could prompt more data center investment to shift to Asia, while industrial and household electricity use will also boost demand.
Tencent released Hy4, expanding image understanding and computer-operation capabilities while keeping API prices unchanged. Morgan Stanley is positive on feedback from office-product use driving model iteration, while Tencent plans to scale up training and narrow the gap with closed-source models.
Datadog’s third-quarter revenue and operating margin both exceeded market consensus, but fourth-quarter revenue guidance was broadly flat quarter over quarter. Morgan Stanley believes assumptions about usage by a large customer and renewal discounts for AI customers are near-term drags, cutting its price target from $300 to $270 while maintaining an Overweight rating.
Arm’s 2027 fiscal second-quarter revenue and earnings per share exceeded market consensus, but royalty revenue was below expectations. The company is more confident in generating up to $2 billion in CPU revenue over two fiscal years combined, while lowering its gross margin outlook for the first-generation product.
AppLovin’s third-quarter revenue grew 14% sequentially, exceeding the company’s earlier guidance of 7%–8%. Morgan Stanley believes upgrades to the game advertising model and e-commerce expansion open up room for growth, but the revenue growth rate in the fourth-quarter guidance falls to about 8%.
Morgan Stanley expects Nike’s revenue base to reset to about 40 billion dollars, as growth in Performance is unlikely to offset contraction in Sportswear and Jordan; even if margins recover to near market consensus, lower revenue would still weigh on earnings.
Morgan Stanley divides software loans into three groups by AI disruption risk: high-risk loans account for 16% of outstanding balances and are concentrated among lower-rated borrowers and those with near-term maturities. Prices and refinancing conditions have diverged markedly, and CLO managers are adjusting their holdings.